Literature DB >> 7811272

A variant of the human corticotropin-releasing factor (CRF) receptor: cloning, expression and pharmacology.

P C Ross1, C M Kostas, T V Ramabhadran.   

Abstract

A variant of the human corticotropin-releasing factor receptor has been characterized. The variant has a 40-amino-acid deletion in the amino-terminal domain of the receptor and is the only form of this receptor detectable in the individual from which it was isolated. In contrast to the high affinity expressed by the normal human CRF receptor, the receptor variant fails to bind [125I]oCRF with high affinity in transfected COS-1 cells. High concentrations of human CRF are required to elevate intracellular cAMP levels in the cells transfected with the variant receptor; EC50 values of 301 and 0.55 nM were obtained in cell expressing the receptor variant and normal CRF receptors, respectively.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7811272     DOI: 10.1006/bbrc.1994.2884

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Molecular cloning and initial characterization of African green monkey (Cercopithecus aethiops) corticotropin releasing factor receptor type 1 (CRF1) from COS-7 cells.

Authors:  Andrzej T Slominski; Michal A Zmijewski; Alexander Pisarchik; Jacobo Wortsman
Journal:  Gene       Date:  2006-11-10       Impact factor: 3.688

Review 2.  Alternative splicing of G protein-coupled receptors: physiology and pathophysiology.

Authors:  Danijela Markovic; R A John Challiss
Journal:  Cell Mol Life Sci       Date:  2009-07-23       Impact factor: 9.261

Review 3.  Consequences of splice variation on Secretin family G protein-coupled receptor function.

Authors:  Sebastian G B Furness; Denise Wootten; Arthur Christopoulos; Patrick M Sexton
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 4.  Mode matches and their locations in the hydrophobic free energy sequences of peptide ligands and their receptor eigenfunctions.

Authors:  A J Mandell; K A Selz; M F Shlesinger
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

5.  An integrated map of corticotropin-releasing hormone signaling pathway.

Authors:  Tejaswini Subbannayya; Lavanya Balakrishnan; Granthali Sudarshan; Jayshree Advani; Santosh Kumar; Riaz Mahmood; Bipin Nair; Ravi Sirdeshmukh; Kanchan K Mukherjee; Sudhir N Umathe; Rajesh Raju; T S Keshava Prasad
Journal:  J Cell Commun Signal       Date:  2013-03-16       Impact factor: 5.782

Review 6.  Human endometrium as a neuroendocrine tissue: expression, regulation and biological roles of endometrial corticotropin-releasing hormone (CRH) and opioid peptides.

Authors:  E Zoumakis; A N Margioris; A Makrigiannakis; C Stournaras; A Gravanis
Journal:  J Endocrinol Invest       Date:  1997-03       Impact factor: 4.256

Review 7.  Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets.

Authors:  Richard L Hauger; Victoria Risbrough; Olaf Brauns; Frank M Dautzenberg
Journal:  CNS Neurol Disord Drug Targets       Date:  2006-08       Impact factor: 4.388

8.  Cardiac CRFR1 Expression Is Elevated in Human Heart Failure and Modulated by Genetic Variation and Alternative Splicing.

Authors:  Anna P Pilbrow; Kathy A Lewis; Marilyn H Perrin; Wendy E Sweet; Christine S Moravec; W H Wilson Tang; Mark O Huising; Richard W Troughton; Vicky A Cameron
Journal:  Endocrinology       Date:  2016-10-18       Impact factor: 4.736

Review 9.  The CRF system, stress, depression and anxiety-insights from human genetic studies.

Authors:  E B Binder; C B Nemeroff
Journal:  Mol Psychiatry       Date:  2009-12-15       Impact factor: 15.992

10.  Molecular and functional characterization of novel CRFR1 isoforms from the skin.

Authors:  Alexander Pisarchik; Andrzej Slominski
Journal:  Eur J Biochem       Date:  2004-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.